Joss F. has a diverse work experience spanning several companies and industries. Most recently, starting in 2020, Joss has been working at Kyowa Kirin International plc. as a Senior Learning & Capability Partner (EMEA). In 2022, Joss took on the role of Head of Talent & Development (EMEA) (Interim) before becoming the Talent & Development Director (EMEA) in 2023.
Prior to joining Kyowa Kirin International plc., Joss held various positions at Novartis from 2012 to 2019, including Learning and Development Manager and Interim Learning & Development Manager. During this time, Joss collaborated with the business to define and implement learning and development strategies for multiple locations and led projects for new product launches.
Before Novartis, Joss worked as an Interim Learning & Development Manager at Nuffield Health in 2012, where they researched, designed, and delivered training solutions for the launch of a new business initiative. In 2011, Joss worked as an Interim Learning & Development Consultant at BMI Healthcare and as an Associate Strategy Consultant at Ashbury Training.
Joss has a long history with Marks & Spencer Plc. and Marks and Spencer, where they held several roles from 1995 to 2011. These roles included Learning Manager, Supply Chain Systems Developer, and Commercial Manager, among others.
With extensive experience in talent development, learning and development strategy, and management, Joss brings a wealth of knowledge to their current role at Kyowa Kirin International plc.
Joss F. attended Collingwood School, but further information regarding their degree or field of study is not provided. In addition to their formal education, Joss F. obtained several certifications, including Organizational Learning and Development and Talent Management from LinkedIn in 2020, Motivational Maps Practitioner from Motivational Maps in 2018, MBTI Step 1 Practitioner from The Myers-Briggs Company in 2008, and a Certificate in Training Practice from CIPD Qualifications in 2003.
This person is not in any offices
Kyowa Kirin International plc.
At Kyowa Kirin International (KKI), commitment to life is at our core. We strive to answer the unmet medical needs of patients, their families, and the medical professionals who care for them. With more than 700 people focused on this purpose, we are a rapidly growing specialty biopharmaceutical company, engaged in the development and commercialisation of innovative medicines in the therapy areas of oncology, nephrology and central nervous system (CNS) across Europe and the Middle East. KKI, headquartered in Marlow, England, and Galashiels, Scotland, is owned by Kyowa Kirin Co., Ltd (KKC), of Japan. Founded in 1949, KKC has a successful track record in Japan and has expanded globally. Our history of innovation is built on a strong legacy of scientific discovery and fostering collaborations that accelerate the delivery of innovative medicines to patients. Grounded in our expertise in antibody engineering, we continue to investigate new molecules with the potential to contribute to the future of healthcare and make a difference in the lives of patients. At KKI, it is our people who have helped make a real difference to our success. Working together, our employees excel in achieving results quickly and effectively, bringing diverse and unique viewpoints to the company to achieve our vision. Our passion and energy around our core values of commitment to life, innovation, integrity and teamwork help ensure that every day, each of us is focused on not just making medicines, but also making people smile. With our strong legacy and exciting future, KKI is looking for great people to join our team and support our commitment to life.